Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Ampullary Adenocarcinoma × Leucovorin × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Colorectal Neoplasms 393 Rectal Neoplasms 196 Colonic Neoplasms 186 Pancreatic Neoplasms 121 Stomach Neoplasms 110 Neoplasm Metastasis 89 Neoplasms 58 Esophageal Neoplasms 54 Precursor Cell Lymphoblastic Leukemia-Lymphoma 45 Lymphoma 42 Leukemia 36 Carcinoma, Hepatocellular 36 Adenocarcinoma Of Esophagus 35 Burkitt Lymphoma 27 Adenocarcinoma 26 Cholangiocarcinoma 24 Biliary Tract Neoplasms 22 Gastrointestinal Neoplasms 19 Gallbladder Neoplasms 19 Carcinoma, Non-Small-Cell Lung 18 Lymphoma, Non-Hodgkin 16 Liver Neoplasms 14 Esophageal Squamous Cell Carcinoma 14 Bile Duct Neoplasms 14 Osteosarcoma 12 Leukemia, Myeloid, Acute 12 Unspecified Adult Solid Tumor, Protocol Specific 11 Lymphoma, Large B-Cell, Diffuse 11 Breast Neoplasms 11 Leukemia, Biphenotypic, Acute 10

Interventions

folfirinox 1 Oxaliplatin 1 Leucovorin 1 Irinotecan 1 Fluorouracil 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06068023 2023-10-05

ADAPTA

Fondazione Poliambulanza Istituto Ospedaliero

Ampullary Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡